Browsing Tag
patents
5 posts
Alternative meat patents are rising, but which country leads the way?
As companies working in alternative meat – cultivated meat, fermentation-made meat and plant-based meat – proliferate, so do new ingredients and new technologies.One thing that has grown alongside them is patents. As companies develop transformative techniques and processes, they need to mark them as intellectual property.Growth of patents in the alternative meat sectorIP in meat
Continuation Patents Have Surged, Disrupting Generic Competition, Study Shows
Special Reports > Features — Researchers caution that abusing patent laws harms patients, stifles innovation by Rachael Robertson, Enterprise & Investigative Writer, MedPage Today August 1, 2023 Continuation patents on FDA-approved drugs skyrocketed by 200% from 2000 to 2015, likely putting off generic competition, researchers found. Over this time period, the ratio of continuation patents
BYD’s New Patents Offer Hints on Yangwang High-End SUVs
Your browser does not support the audio element. On the evening of November 8, Chinese automaker BYD unveiled a new high-end vehicle brand called Yangwang, with model prices falling in the million-yuan range, sparking fervent discussion in China. Three days later, several automobile patents applied for by BYD were made public, revealing the possible design
Samsung patents handset with L-shaped display
I can't see this ever coming out Well, this is a weird one. Samsung’s latest patent showcases a phone with an L-shape when unfolded. When it’s folded the screen wraps around the rear, almost touching the camera sensors. This patent was originally posted by LetsGoDigital partnered with Concept Creator to create cool concepts using the…
The characteristics of patents impacting availability of biosimilars
The large number of biologic drug patents in the United States has contributed to delays in biosimilar availability. Biologic drugs such as monoclonal antibodies and gene therapies have become mainstays in the treatment of many diseases, but also focal points in the debate over pharmaceutical pricing. Biologics accounted for 48% of net manufacturer revenue and…